Ross Haghighat

临床试验

首次发布于 2017 年 1 月 23 日

终止

NCT00267995

Ross Aortic Valve Replacement Patients

计划入组 75 人 · 首次发布于 2005 年 12 月 22 日

已完成

NCT01242670

Ross River Virus (RRV) Vaccine Study

计划入组 1,968 人 · 首次发布于 2010 年 11 月 17 日

药物

查看全部 83 →

Ross River Virus Vaccine(Ology Bioservices)

Ross River virus vaccine (National Resilience)

Biotech

Approved

Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen(Pedvaxhib, Vaxelis)

相关疾病：Invasive Infection caused by Haemophilus Influenzae Type B

机构

查看全部 59 →

Hays, Ross

United States

THORNTON & ROSS LIMITED

United Kingdom

Thornton & Ross Ltd.

United Kingdom

资讯

查看全部 597 →

去年

Sernova Biotherapeutics Chairman Ross Haghighat Resigns as Company Advances Type 1 Diabetes Cell Therapy

3个月前

Memorial Sloan Kettering Highlights Patient-Centered Oncology with Profiles of Dr. Jessica Ross and Dr. Joshua Drago

3个月前

临床试验

Ross Operation Failure Database

Ross Aortic Valve Replacement Patients

Ross River Virus (RRV) Vaccine Study

药物

Ross River Virus Vaccine(Ology Bioservices)

Ross River virus vaccine (National Resilience)

Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen(Pedvaxhib, Vaxelis)

机构

Hays, Ross

THORNTON & ROSS LIMITED

Thornton & Ross Ltd.

资讯

Sernova Biotherapeutics Chairman Ross Haghighat Resigns as Company Advances Type 1 Diabetes Cell Therapy

Memorial Sloan Kettering Highlights Patient-Centered Oncology with Profiles of Dr. Jessica Ross and Dr. Joshua Drago

SOPHiA GENETICS Shareholders Approve Leadership Transition: Ross Muken to Become CEO, Co-Founder Jurgi Camblong Elected Executive Chairman